Julia W. Erath - Publications

OPTimizing Beta-Blocker Dosage in Women Using the Wearable Cardioverter-Defibrillator (OPT-BB Women): Study design.

Journal: Heart rhythm O2

Published: March 30, 2026

Major Bleeding With Apixaban vs Aspirin: A Subanalysis of the ARTESiA Randomized Clinical Trial.

Journal: JAMA cardiology

Published: November 12, 2025

Subclinical atrial fibrillation and the risk of heart failure: insights from ARTESiA.

Journal: European journal of heart failure

Published: October 22, 2025

Cost-effectiveness of apixaban vs. aspirin for the reduction of thrombo-embolism in high-risk patients with device-detected atrial fibrillation: insights from the ARTESiA trial.

Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

Published: July 29, 2025

Efficacy and safety of the subcutaneous implantable cardioverter defibrillator in patients with and without obesity: An international, bicentric retrospective registry.

Journal: Clinical research in cardiology : official journal of the German Cardiac Society

Published: July 03, 2025

Apixaban versus aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischaemic attack: subgroup analysis of the ARTESiA randomised controlled trial.

Journal: The Lancet. Neurology

Published: August 14, 2024

Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials.

Journal: European heart journal

Published: July 26, 2024

Sex differences in achieving guideline-recommended heart rate control among a large sample of patients at risk for sudden cardiac arrest.

Journal: Heart rhythm O2

Published: June 06, 2024

Association of BMI with adherence and outcome in heart failure patients treated with wearable cardioverter defibrillator.

Journal: ESC heart failure

Published: May 03, 2024

Predictors of ventricular tachyarrhythmia in patients with a wearable cardioverter defibrillator: an international multicenter registry.

Journal: Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing

Published: April 18, 2024

Clinical Impact of Digitalis Therapy in a Large Multicenter Cohort of CRT-Recipients.

Journal: Journal of cardiovascular development and disease

Published: April 16, 2024

No beneficial use of the wearable cardioverter defibrillator among patients suffering from inherited and congenital heart disease: data from a European multicenter registry.

Journal: Frontiers in cardiovascular medicine

Published: February 10, 2024